Overview

A Study of MK0476 in the Treatment of Asthma Patients Aged 2-5 Years (0476-907)

Status:
Completed
Trial end date:
2002-12-01
Target enrollment:
Participant gender:
Summary
A study to determine the efficacy of MK0476 in the Treatment of Asthmatic Patients Aged 2 to 5 Years.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Montelukast